Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-08

Clinical Trial Update: A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response [NA]

View source ↗

Summary

A completed trial evaluated gabapentin for vulvodynia and examined biological correlates of response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: University of Tennessee | Conditions: Vulvodynia | NA | Status: COMPLETED | Results posted: 2017-11-08